Regulation of Jak2 through the ubiquitin-proteasome pathway involves phosphorylation of Jak2 on Y1007 and interaction with SOCS-1

Molecular and Cellular Biology

Volumn 22, Issue 10, 2002, Pages 3316-3326

  Ungureanu, Daniela ^a   Saharinen, Pipsa ^a   Junttila, Ilkka ^a   Hilton, Douglas J ^a   Silvennoinen, Olli ^a  

^a UNIVERSITY OF TAMPERE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 3; JANUS KINASE; LIGAND; MUTANT PROTEIN; PROTEASOME; PROTEASOME INHIBITOR; PROTEIN; PROTEIN Y1007; SUPPRESSOR OF CYTOKINE SIGNALING; TYROSINE; UBIQUITIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CATALYSIS; CELL SURVIVAL; COMPLEX FORMATION; CONTROLLED STUDY; DIMERIZATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME METABOLISM; ENZYME PHOSPHORYLATION; ENZYME REGULATION; GENE EXPRESSION REGULATION; HOMEOSTASIS; MOLECULAR STABILITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALS; CARRIER PROTEINS; CELL FRACTIONATION; COS CELLS; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; HUMANS; INTERFERON TYPE II; INTERLEUKIN-3; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; JANUS KINASE 2; LEUPEPTINS; MULTIENZYME COMPLEXES; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TYROSINE; UBIQUITIN;

ANIMALIA; JANUS;

EID: 0036233985     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.22.10.3316-3326.2002     Document Type: Article

References (58)

1. SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine
2. Suppressors of cytokine signaling (SOCS): Negative regulators of signal transduction
3. Suppressor of cytokine signaling-1 attenuates the duration of interferon gamma signal transduction in vitro and in vivo
4. Interleukin-3-induced activation of the JAK/STAT pathway is prolonged by proteasome inhibitors
5. SOCS proteins, regulators of intracellular signaling
6. The ubiquitin-proteasome pathway: On protein death and cell life
7. SOCS-3 is tyrosine phosphorylated in response to interleukin-2 and suppresses STAT5 phosphorylation and lymphocyte proliferation
8. Deubiquitinating enzymes: A new class of biological regulators
9. Suppressor of cytokine signaling-1 inhibits VAV function through protein degradation
10. Inhibition of transcription elongation by the VHL tumor suppressor protein
11. A new protein containing an SH2 domain that inhibits JAK kinases
12. Activation of Jak2 catalytic activity requires phosphorylation of Y1007 in the kinase activation loop
13. Socs-1 Inhibits TEL-JAK2-mediated transformation of hematopoietic cells through inhibition of JAK2 kinase activity and induction of proteasome-mediated degradation
14. Termination of growth hormone pulse-induced STAT5b signaling
15. Ubiquitin-mediated degradation of active Src tyrosine kinase
16. The rapid inactivation of nuclear tyrosine phosphorylated Statl depends upon a protein tyrosine phosphatase
17. Protein regulation by monoubiquitin
18. Twenty proteins containing a C-terminal SOCS box form five structural classes
19. Signaling through the hematopoietic cytokine receptors
20. The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2
21. The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families
22. Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C
23. Dual signaling role of the protein tyrosine phosphatase SHP-2 in regulating expression of acute-phase plasma proteins by interleukin-6 cytokine receptors in hepatic cells
24. Regulation of interferon-gamma-activated STATI by the ubiquitin-proteasome pathway
25. Regulation of Jak2 tyrosine kinase by protein kinase C during macrophage differentiation of IL-3-dependent myeloid progenitor cells
26. A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia
27. Substrate targeting in the ubiquitin system
28. Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1
29. Ciliary neurotrophic factor and phorbol ester each decrease selected STAT3 pools in neuroblastoma cells by proteasome-dependent mechanisms
30. SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality
31. E2/E3-mediated assembly of lysine 29-linked polyubiquitin chains
32. Aberrant hematopoiesis in mice with inactivation of the gene encoding SOCS-1
33. Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor
34. Structure and function of a new STAT-induced STAT inhibitor
35. Three distinct domains of SSI-1/SOCS-1/JAB protein are required for its suppression of interleukin 6 signaling
36. Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130
37. Proteome analysis reveals ubiquitin-conjugating enzymes to be a new family of interferon-alpha-regulated genes
38. Regulation of the Src family tyrosine kinase Blk through E6AP-mediated ubiquitination
39. Jak2 is essential for signaling through a variety of cytokine receptors
40. SOCS/CIS protein inhibition of growth hormone-stimulated STAT5 signaling by multiple mechanisms
41. Regulation of the Jak2 tyrosine kinase by its pseudokinase domain
42. Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain
43. Different protein turnover of interleukin-6-type cytokine signalling components
44. Cytokine receptor signal transduction through Jak tyrosine kinases and Stat transcription factors
45. Structure of the murine Jak2 protein-tyrosine kinase and its role in interleukin 3 signal transduction
46. A family of cytokine-inducible inhibitors of signalling
47. The ubiquitin conjugation system is required for ligand-induced endocytosis and degradation of the growth hormone receptor
48. The proteasome: A protein-destroying machine
49. Proteasomes regulate erythropoietin receptor and signal transducer and activator of transcription 5 (STAT5) activation. Possible involvement of the ubiquitinated Cis protein
50. Proteasomes regulate the duration of erythropoietin receptor activation by controlling down-regulation of cell surface receptors
51. A small amphipathic alpha-helical region is required for transcriptional activities and proteasome-dependent turnover of the tyrosine-phosphorylated Stat5
52. The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop
53. A dual role for the kinase-like domain of the tyrosine kinase Tyk2 in interferon-alpha signaling
54. Involvement of the ubiquitin-proteasome pathway in the degradation of nontyrosine kinase-type cytokine receptors of IL-9, IL-2, and erythropoietin
55. Src-catalyzed phosphorylation of c-Cbl leads to the interdependent ubiquitination of both proteins
56. Involvement of proteasomes in regulating Jak-STAT pathways upon interleukin-2 stimulation
57. The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation
58. The SOCS box of suppressor of cytokine signaling-1 is important for inhibition of cytokine action in vivo